Clinical trial
Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy: A Randomized Controlled Trial
NCT04374188 is registered in ClinicalTrials.gov with Diaa Eldin Taha Ramadan Mohamed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy: A Randomized Controlled Trial
- Lead sponsor
- Diaa Eldin Taha Ramadan Mohamed
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2019
- Completion date
- March 1, 2022
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.